Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Account Payables
Amounts the company owes suppliers for goods and services received.
Microbot Medical Inc.NASDAQ: MBOT
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 483.3% from a year ago
Account payables stood at $1.09M at the end of Q1 FY2026, up 483.3% from a year earlier and up 112.3% from the prior quarter. Over 3 fiscal years it compounded at +63.9% a year.
Context
- Account payables amounted to 1.4% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +483.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 511K USD
- Year-over-year change
- +209.7%
- 4-year CAGR
- +16.3%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 511K | +209.7% |
| FY2024 | 2024-12-31 | 165K | -53.8% |
| FY2023 | 2023-12-31 | 357K | +207.8% |
| FY2022 | 2022-12-31 | 116K | -58.4% |
| FY2021 | 2021-12-31 | 279K | — |
Account Payables vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +483.3% is the highest of 10, against a peer median of -5.5%.
- Account payables amounts to 1.4% of total assets for MBOT, versus a peer median of 4.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $13.87M USD | -32.4% | -19.9% | 6.6% | |
| Mar 2026 | $8.88M USD | +355.2% | +0.1% | 3.9% | |
| Mar 2026 | $7.22M USD | -16.8% | +44.0% | 14.0% | |
| Mar 2026 | $2.47M USD | +146.3% | +39.3% | 4.2% | |
| Mar 2026 | CA$2.09M CAD | +4.1% | +31.9% | 13.8% | |
| Mar 2026 | $1.47M USD | +45.9% | -4.3% | 3.5% | |
| Mar 2026 | $1.31M USD | -7.4% | -33.4% | 6.0% | |
| Mar 2026 | $1.09M USD | +483.3% | +63.9% | 1.4% | |
| Mar 2026 | $481K USD | -5.5% | -41.2% | 0.2% | |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding MBOT) | — | -5.5% | -2.1% | 4.2% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.